Clinical Trial Update: Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 study evaluating the cardiac hemodynamics and safety of SLV320 in subjects with congestive heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SLV320

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Congestive Heart Failure | Phase 2 | Status: COMPLETED